FRATTA, WALTER
 Distribuzione geografica
Continente #
EU - Europa 175.819
NA - Nord America 13.495
AS - Asia 1.672
AF - Africa 38
SA - Sud America 25
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 16
Totale 191.084
Nazione #
IT - Italia 171.836
US - Stati Uniti d'America 13.426
UA - Ucraina 1.469
CN - Cina 1.365
SE - Svezia 898
DE - Germania 503
GB - Regno Unito 452
FI - Finlandia 370
FR - Francia 126
IN - India 84
TR - Turchia 68
CA - Canada 61
RU - Federazione Russa 53
SG - Singapore 53
VN - Vietnam 38
BE - Belgio 32
NL - Olanda 25
BR - Brasile 22
MU - Mauritius 22
AU - Australia 16
EU - Europa 16
IE - Irlanda 11
IR - Iran 11
KR - Corea 8
LB - Libano 8
CZ - Repubblica Ceca 7
MX - Messico 7
JP - Giappone 6
PK - Pakistan 6
HU - Ungheria 4
NG - Nigeria 4
SA - Arabia Saudita 4
AT - Austria 3
CH - Svizzera 3
EG - Egitto 3
ES - Italia 3
HR - Croazia 3
IL - Israele 3
MT - Malta 3
NZ - Nuova Zelanda 3
PH - Filippine 3
RO - Romania 3
RS - Serbia 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
HK - Hong Kong 2
KE - Kenya 2
MY - Malesia 2
PL - Polonia 2
PT - Portogallo 2
SC - Seychelles 2
TH - Thailandia 2
TW - Taiwan 2
TZ - Tanzania 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BD - Bangladesh 1
CO - Colombia 1
GE - Georgia 1
ID - Indonesia 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 191.084
Città #
Cagliari 171.079
Fairfield 1.716
Woodbridge 1.384
Chandler 1.362
Ann Arbor 990
Houston 948
Ashburn 920
Jacksonville 799
Wilmington 720
Seattle 661
Cambridge 576
Nyköping 573
Dearborn 498
Boardman 340
Nanjing 286
Beijing 195
Boston 187
Helsinki 145
New York 106
Shanghai 106
Milan 102
Shenyang 102
San Diego 97
Hebei 80
Redwood City 78
Nanchang 74
Mountain View 65
Verona 59
Guangzhou 58
Jiaxing 56
Changsha 53
Washington 52
Tianjin 47
Sassari 43
Jinan 39
Toronto 39
Orange 38
Dong Ket 37
Hefei 37
London 37
Norwalk 35
Pune 33
Santa Maria Coghínas 33
Brussels 31
Auburn Hills 30
Zhengzhou 29
Ningbo 27
Kunming 25
Los Angeles 25
Kocaeli 23
Atlanta 22
Rome 22
Hangzhou 17
Istanbul 15
Falls Church 14
Paris 14
Saint Petersburg 13
San Mateo 12
Chengdu 11
Ottawa 11
Taizhou 11
Arlington 10
Walnut 10
Dublin 9
Redmond 9
Wuhan 9
Borås 8
Mumbai 8
Quartu Sant'elena 8
San Sperate 8
Tertenìa 8
Amsterdam 7
Frankfurt am Main 7
Fuzhou 7
Chongqing 6
Detroit 6
Indiana 6
Naples 6
Phoenix 6
Renton 6
San Francisco 6
Zhangzhou 6
Augusta 5
Edinburgh 5
Fremont 5
Leawood 5
Modena 5
Monmouth Junction 5
Montague 5
Quartu Sant'Elena 5
Simi Valley 5
Stockholm 5
Ankara 4
Arezzo 4
Cedar Knolls 4
Dolo 4
Hounslow 4
Iglesias 4
Kilburn 4
Melbourne 4
Totale 185.475
Nome #
PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors. 4.182
BEHAVIORAL EFFECTS OF ACUTE ADMINISTRATION OF THE PPAR-α AGONIST PALMITOYLETHANOLAMIDE IN RATS 3.190
Adolescent Δ 9-Tetrahydrocannabinol exposure alters WIN55,212-2 self-administration in adult rats 3.090
PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS ALPHA AGONISTS ANTIDEPRESSANT-LIKE EFFECT: BEHAVIORAL CHARACTERIZATION IN RATS 3.075
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives 3.041
Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing To Drug Addiction: Effect of Ovarian Hormones. 3.002
Cannabinoid CB1/CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia 2.881
Emotional profile of female rats showing binge eating behavior 2.804
Limited access to a high fat diet alters endocannabinoid tone in female rats 2.768
Sex-specific differences in cannabinoid-induced extracellular-signal-regulated kinase phosphorylation in the cingulate cortex, prefrontal cortex, and nucleus accumbens of Lister Hooded rats 2.748
Acute administration of palmitoylethanolamide: behavioural studies 2.726
Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation 2.719
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence. 2.661
Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat 2.607
Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats 2.600
Antidepressant-like effect of clofibrate: a synthetic PPAR-a agonist 2.586
Adolescent THC exposure and vulnerability to drug abuse: Sex differences 2.554
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study 2.539
Sex differences in addictive disorders 2.382
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 2.368
Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex 2.278
Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings 2.271
Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa 2.248
BDNF serum levels as a biomarker of depressive symptoms in psychotic disorders 2.240
The endocannabinoid system: Anorexia nervosa and binge eating disorder 2.119
The longitudinal trajectory of serum brain-derived neurotrophic factor (BDNF) levels in psychotic patients: a prospective observational study 2.107
Role of opioid receptors in the reinstatement of opioid-seeking behavior: an overview 2.079
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats. 2.071
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function 2.071
Brain activity of anandamide: a rewarding bliss? 1.991
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 1.987
Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors 1.978
CB2 antagonist AM630, monoacylglycerol lipase inhibitor JZL184 and cannabidiol did not affect hedonic properties of food in rats with binge eating behavior 1.949
Analysis of opioid-seeking reinstatement in the rat 1.939
New perspectives on the use of cannabis in the treatment of psychiatric disorders 1.928
Gene knockout animal models of depression, anxiety and obsessive compulsive disorders 1.897
Methoxetamine affects brain processing involved in emotional response in rats 1.881
Antidepressant-like effect of clofibrate: a synthetic PPAR-α agonist 1.793
Chronic Blockade of CB1 Receptors Reverses Startle Gating Deficits and Associated Neurochemical Alterations in Isolation Reared Rats. 1.703
CANNABINOID-INDUCED ALTERATION IN THE EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) SIGNALLING PATHWAY IN MALE, FEMALE AND OVARIECTOMIZED RATS 1.645
null 1.579
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid 1.574
THC exposure during adolescence increases cannabinoid and heroin intake in female rats more than in males 1.557
Evaluation of behavioral phenotypes in rats showing binge eating behavior 1.526
Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine 1.518
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats 1.402
Altered brain levels of arachidonic acid-derived inflammatory eicosanoids in a rodent model of anorexia nervosa 1.360
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking 1.357
The endocannabinoid system and nondrug rewarding behaviours 1.316
Role of the endocannabinoid system in the central mechanisms regulating motivation for food 1.292
Effects of modulation of endocannabinoid system on fat intake under a limited-access protocol of binge eating in female rats 1.279
Drug and cue induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones 1.265
The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats. 1.215
Conditioned place preference (CPP) in rats: From conditioning to reinstatement test 1.191
Hippocampal theta activity is modulated by cannabinoid type1receptor in rats 1.182
Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents 1.131
Rimonabant reduces fat intake under a limited access protocol of binge eating disorder 1.126
Dopamine-beta-hydroxylase inhibition potentiates cocaine effect on dopamine release in the medial prefrontal cortex 1.118
Neurobiological mechanisms of cannabinoid addiction 1.090
Adolescent THC Exposition and vulnerability to Nicotine abuse 1.077
Cannabinoid self-administration in rats: sex differences and the influence of ovarian function 1.002
Brain proteolysis of oxytocin "in vitro" and "in vivo" changes during aging in male rats 954
Nicotine consumption is regulated by a human polymorphism in dopamine neurons. 904
Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors 879
The GABA(B) receptor agonist baclofen prevents heroin-induced reinstatement of heroin-seeking behavior in rats 865
Cannabis: THC and beyond. Atto II 858
Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs 854
Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats 845
Lead intoxication during intrauterine life and lactation but not during adulthood reduces nucleus accumbens dopamine release as studied by brain microdialysis 842
Molecular mechanisms of cannabinoid addiction 826
Cannabinoids and their therapeutic applications in mental disorders 825
Dopamine and serotonin release in dorsal striatum and nucleus accumbens is differentially modulated by morphine in DBA/2J and C57BL/6J mice 820
Endocannabinoid system and opioid addiction: behavioural aspects 813
Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats 806
Oxytocin concentration changes in different rat brain areas but not in plasma during aging 779
An endocannabinoid mechanism in relapse to drug seeking: A review of animal studies and clinical perspectives 770
The endocannabinoid system: a new molecular target for the treatment of tobacco addiction 751
Cannabinoid-opioid interaction in relapse to drug-seeking 743
null 738
Benzodiazepines induced voraciousness in cats and inhibition of amphetamine anorexia 738
null 711
The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition 666
Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats. 656
An altered thyroid status does not alter the met-enkephalin plasma concentration in humans 651
Changed accumbal responsiveness to alcohol in rats pre-treated with nicotine or the cannabinoid receptor agonist WIN 55,212-2 647
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 643
null 635
Effect of Baclofen on Nicotine, Cocaine and Morphine-induced dopamine release in the shell portion of the nucleus accumbens of rat 620
null 615
Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat 610
Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats 603
CB1 agonist administration modify 5-HT release in the nucleus accumbens and striatum of freely moving rats 600
Nicotinic α7 receptors as a new target for treatment of cannabis abuse 574
Localized epileptiform activity induced by murine CRF in rats 570
The CB1 receptor antagonist AM251 blocks drug-induced reinstatement of nicotine conditioned place preference in rats 549
Sex differences in the self-administration of cannabinoids and other drugs of abuse 549
Beyond THC: the new generation of cannabinoid designer drugs 544
Failure of ketamine to interact with opiate receptors 533
Involvement of the 5-HT1a serotonergic receptors in the anxiety-like effects induced by the CB1 cannabinoid receptor agonist WIN 55,212-2 527
The effect of D- and L-p-chlorophenylalanine on the metabolism of 5-hydroxytryptamine in brain 503
Totale 151.471
Categoria #
all - tutte 244.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 244.459


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.184 0 0 0 0 0 0 0 0 0 0 1.084 1.100
2019/202044.728 2.527 1.139 336 1.252 15.330 11.549 6.207 1.664 1.085 893 1.208 1.538
2020/202155.474 2.078 2.234 2.748 15.372 10.888 6.560 5.480 3.165 1.018 2.157 2.047 1.727
2021/202211.216 1.328 895 443 946 1.277 879 632 526 911 1.123 1.192 1.064
2022/202316.693 1.473 1.885 2.030 1.361 1.378 1.732 812 1.590 1.255 1.061 1.407 709
2023/202414.659 988 634 897 1.429 1.726 3.047 2.283 1.082 983 1.379 211 0
Totale 191.578